Johnson & Johnson to buy Cougar Biotechnology
May 27, 2009Research and Development, Sales and Marketing Cougar, J&J, JJ
Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …
Demonstrating value to boost product uptake
May 27, 2009Sales and Marketing marketing, product, value
I am sure that every marketer reading Pharmafocus is convinced of the value of their brand. Why then do so …
Pharma manufacturing: News in Brief
May 27, 2009Manufacturing and Production Lonza
Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including new facility updates from Alcon, Lonza, Cell Therapeutics, …
UK government ignores biotech pleas for cash
May 27, 2009Research and Development biotech
The UK biotech sector says the government's failure to provide urgently needed financial assistance is jeopardising its future.Industry body the …
GP targets drive up COPD prescribing
May 27, 2009Sales and Marketing COPD, NHS, qof
Respiratory drugs saw the biggest growth in GP prescribing in England in 2008, thanks to new COPD targets.The rapid growth …
Almirall opens UK headquarters
May 27, 2009Sales and Marketing Almirall
Spanish pharma company Almirall has opened its new UK and Ireland headquarters in West London's Stockley Park.The site will be …
Quotient buys Scottish clinical unit from Charles River
May 26, 2009Research and Development Charles River, Quotient
Contract research organisation Quotient Bioresearch has acquired a facility from Charles River Laboratories that will boost its capabilities in the …
MedeConnect launches next generation of online doctor surveys
May 21, 2009Medical Communications MedConnect
The market research arm of online doctors' community Doctors.net.uk has launched a new qualitative market research service which expands the …
Sanofi launches web TV channel
May 21, 2009Sales and Marketing Sanofi-Aventis, digi
Sanofi-Aventis has set up an online television channel to promote its business, commitment to social responsibility and employee activities. To …
Omnicom opens new healthcare coms agency
May 21, 2009Medical Communications TogoRun
Media giant the Omnicom Group has launched a TogoRun, a new healthcare communications agency with offices in London and New …
Phase III drug superior to Spiriva, says Novartis
May 21, 2009Research and Development, Sales and Marketing COPD, Novarits
Novartis says its COPD treatment has shown significant benefits over two established rivals, and could form the cornerstone of a …
Pfizer signs Indian generic deals
May 21, 2009Sales and Marketing Pfizer, generics
Pfizer has expanded its presence in the generics market with deals that see it licence 75 products from two Indian …
Mexican flu: contained but not beaten
May 21, 2009Research and Development Mexico, Vaccine, flu, pandemic
Global efforts to limit the impact of the new strain of H1N1 flu virus have proven successful, but the threat …
ABPI looks to breathe new life into industry relations
May 20, 2009Medical Communications, Sales and Marketing ABPI, doctors, industry relations, medical education, vita
The ABPI has unveiled a new proactive agenda which it hopes will help improve the industry’s reputation and relationships with …
Takeda to market new bone cancer drug
May 20, 2009Research and Development, Sales and Marketing MA, Takeda
Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …
Cannabis-derived MS drug filed for European approval
May 20, 2009Research and Development, Sales and Marketing GW, Sativex
Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …
EFPIA plans counterfeit crackdown
May 20, 2009Manufacturing and Production, Research and Development EFPIA, counterfeits
European pharmaceutical industry association EFPIA has unveiled a new scheme to crack down on counterfeit medicines.Beginning with a trial run …
SkyePharma cuts staff at French and Swiss facilities
May 20, 2009Research and Development, Sales and Marketing Skyepharma
SkyePharma has moved ahead with plans to cut its workforce at a manufacturing plant in France by a third as …
EU gives the nod to Teva/Lonza biosimilar venture
May 18, 2009Manufacturing and Production, Sales and Marketing Lonza, Teva
The European Commission has given a green light to the formation of a joint venture company between Teva and Lonza …
The medical-marketing interface and how to bridge the gap
May 18, 2009Research and Development, Sales and Marketing marketing, medical
Drug companies are not charities and are accountable to their shareholders, as we all know. Products have to be sold …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
